Cardiol Therapeutics (CRDL) Interest & Investment Income (2020 - 2026)

Cardiol Therapeutics has reported Interest & Investment Income for 7 years, with the latest figure at $146369.1 in Q1 2026.

• For the quarter ending Q1 2026, Interest & Investment Income fell 15.4% year-over-year to $146369.1; the trailing twelve-month figure through Mar 2026 stood at $146369.1 (down 15.4% YoY), and the FY2025 full-year result was $520892.2, down 39.02% from the prior year.
• Interest & Investment Income for Q1 2026 stood at $146369.1, down from $400515.4 in the prior quarter.
• The five-year high for Interest & Investment Income was $1.2 million in Q3 2023, with the low at $57087.8 in Q1 2022.
• Historically, Interest & Investment Income has averaged $431885.6 across 5 years, with a median of $400515.4 in 2025.
• Annual changes were most pronounced in 2022 — Interest & Investment Income surged 705.59% — and 2024, when it plunged 45.21%.
• Cardiol Therapeutics' Interest & Investment Income stood at $500673.8 in 2022, then jumped by 136.91% to $1.2 million in 2023, then sank by 45.21% to $649901.0 in 2024, then tumbled by 38.37% to $400515.4 in 2025, then tumbled by 63.45% to $146369.1 in 2026.
• The last three Interest & Investment Income figures came in at $146369.1 (Q1 2026), $400515.4 (Q3 2025), and $309568.5 (Q2 2025), per Business Quant data.